Has Ken Lee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,811 in general payments to Ken Lee, MD across 264 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ken Lee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ken Lee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ken Lee, MD

Anesthesiology · Boston, MANPI 1013440643

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,833 of the $19,811 with a category attached, or 64.8%. 15 manufacturers reported payments, led by Medtronic at 24.3% of the total. Among anesthesiology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,811in general payments, 2019–2025

Across 264 payments — averaging $75.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$5K
Boston Scientific$5K
Saluda Medical Americas, Inc.$4K
MML US, Inc.$3K
Abbott$2K
Vertos Medical, Inc.$473
plus $1K from 9 others

What the payments were for

Travel & lodging$6,97835%
Food & beverage$12,83365%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	95	$4,813
Boston Scientific	47	$4,543
Saluda Medical Americas, Inc.	57	$4,393
MML US, Inc.	18	$2,682
Abbott	20	$1,826
Vertos Medical, Inc.	5	$473
Nevro Corp.	7	$319
SPR Therapeutics, Inc	2	$204
Globus Medical	2	$155
Stryker	4	$126
Piramal Critical Care	1	$117
Bioventus LLC	2	$57
Johnson & Johnson	2	$37
Pacira Pharmaceuticals Incorporated	1	$33
AbbVie	1	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Evoke$3,315
ReActiv8$2,366
INTELLIS ADAPTIVESTIM$1,708
Superion Indirect Decompression System$1,520
Proclaim IPG$1,108
WaveWriter Alpha Prime 16$810
WAVEWRITER ALPHA$622
INCEPTIV$469
GABLOFEN$469
mild Device Kit$461
SYNCHROMEDII$461
Evoke SCS$296
Proclaim DRG IPG$244
GENERAL VASCULAR ACCESS$202
GENERAL PAIN MANAGEMENT$150
Omnia$134
Senza$128
SPRINT PNS System$112

How this compares

$19,811 in reported general payments places this provider in the 95th percentile of 1,585 anesthesiology providers in Massachusetts.

See all anesthesiology providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$185,672

Medicare patients

445

Services billed

16,995

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	16	$2,317
Pregabalin	89	$1,786
Diclofenac Sodium	31	$1,296
Gabapentin	66	$713
Tizanidine Hcl	37	$451
Cyclobenzaprine Hcl	22	$324
Duloxetine Hcl	14	$302
Oxycodone Hcl	32	$291
Methocarbamol	18	$251
Meloxicam	40	$120
Methylprednisolone	17	$95
Tramadol Hcl	11	$58

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Boston

Douglas ShookBoston$267K
Robert YongBoston$231K
Michael DambraBoston$194K
Robert TruogBoston$172K
Mary Ellen McCannBoston$140K
Stanton ShernanBoston$136K
Edgar RossBoston$129K
Sadeq QuraishiBoston$107K
James PhilipBoston$56K
Feroze Ud Din MahmoodBoston$51K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →